Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Tested positive (at home test) on 02Feb2022.; Tested positive (at home test) on 02Feb2022.; sore throat; runny nose; low-grade fever; cough; hoarse voice; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Aug2021 at 16:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Penicillin" (unspecified if ongoing); "known allergies: Kiwi" (unspecified if ongoing), notes: known allergies: Kiwi. The patient took concomitant medications. Past drug history included: Ceftin, reaction(s): "allergy"; Iodine, reaction(s): "allergy". Vaccination history included: BNT162b2 (vaccine administration date 25Mar2021,, vaccine administration time: 06:30 PM, vaccine lot unknown: True, vaccine lot unknown reason: Unable to locate or read the details, vaccine dose number unknown: True,, vaccine dose number unknown reason: Unknown, vaccine location: Right arm), administration date: 25Mar2021, for COVID-19 immunization; BNT162b2 (vaccine administration date=15Apr2021,, vaccine administration time: 07:00 PM, vaccine lot unknown: True, vaccine lot unknown reason: Unable to locate or read the details, vaccine dose number unknown=True, vaccine dose number unknown reason: Unknown, vaccine location: Right arm), administration date: 15Apr2021, for COVID-19 immunization. The following information was reported: COUGH (non-serious) with onset 01Feb2022, outcome "recovered" (Feb2022); DYSPHONIA (non-serious) with onset 01Feb2022, outcome "recovered" (Feb2022), described as "hoarse voice"; PYREXIA (non-serious) with onset 01Feb2022, outcome "recovered" (Feb2022), described as "low-grade fever"; RHINORRHOEA (non-serious) with onset 01Feb2022, outcome "recovered" (Feb2022), described as "runny nose"; OROPHARYNGEAL PAIN (non-serious) with onset 01Feb2022, outcome "recovered" (Feb2022), described as "sore throat"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 02Feb2022, outcome "recovered" (Feb2022) and all described as "Tested positive (at home test) on 02Feb2022.". The patient underwent the following laboratory tests and procedures: Pyrexia: (01Feb2022) low-grade; SARS-CoV-2 test: (02Feb2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19, oropharyngeal pain, rhinorrhoea, pyrexia, cough, dysphonia. Clinical course: On 01Feb2022 came down with Covid-19 omicron symptoms (sore throat, runny nose, low-grade fever, cough, hoarse voice. Tested positive (at home test) on 02Feb2022. Began 5-day paxlovid course ending on 07Feb. Symptoms abated during that time and I tested negative on at-home test on or about 7Feb or 8. Several days later I came down with the same symptoms and again tested positive. Waited for it to resolve several days to a week later when I tested negative per at-home test. Other medications was received in 2weeks was anti viral. Treatment start date was 02Feb2022 and stop date was 07Feb2022 (lot number: FT5407).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.